22nd Century Group Archives | Be Korea-savvy
22nd Century Group Announces South Korea as First VLN® International Market

22nd Century Group Announces South Korea as First VLN® International Market

BUFFALO, N.Y., Feb. 28 (Korea Bizwire) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced the $1.6 billion1 South Korean tobacco market will be the first international market to commence sales of its VLN® reduced nicotine [...]

FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product

FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product

BUFFALO, N.Y., Dec. 23 (Korea Bizwire) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that the U.S. Food and Drug Administration (FDA) has authorized the marketing of the Company’s VLN® King and VLN® Menthol King reduced [...]